bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: cipla usa inc.,
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler cipla usa inc.,
Dosage Form TABLET
Routes
ORAL
Active Ingredients

bupropion hydrochloride 100 mg/1

Manufacturer
CIPLA USA INC.,

Identifiers & Regulatory

Product NDC 69097-918
Product ID 69097-918_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207389
Listing Expiration 2026-12-31
Marketing Start 2018-05-26

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097918
Hyphenated Format 69097-918

Supplemental Identifiers

RxCUI
993687 993691
UPC
0369097918071 0369097917074
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA207389 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (69097-918-02)
  • 100 TABLET in 1 BOTTLE (69097-918-07)
  • 1000 TABLET in 1 BOTTLE (69097-918-15)
source: ndc

Packages (3)

Ingredients (1)

bupropion hydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee", "openfda": {"upc": ["0369097918071", "0369097917074"], "unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["e4100232-a25d-4468-9057-af7e66205154"], "manufacturer_name": ["CIPLA USA INC.,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-918-02)", "package_ndc": "69097-918-02", "marketing_start_date": "20180526"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-918-07)", "package_ndc": "69097-918-07", "marketing_start_date": "20180526"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-918-15)", "package_ndc": "69097-918-15", "marketing_start_date": "20180526"}], "brand_name": "bupropion Hydrochloride", "product_id": "69097-918_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69097-918", "generic_name": "bupropion Hydrochloride", "labeler_name": "CIPLA USA INC.,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA207389", "marketing_category": "ANDA", "marketing_start_date": "20180526", "listing_expiration_date": "20261231"}